96 related articles for article (PubMed ID: 19029228)
1. Should genetic testing be performed in each patient with sporadic pheochromocytoma at presentation?
Pigny P; Cardot-Bauters C; Do Cao C; Vantyghem MC; Carnaille B; Pattou F; Caron P; Wemeau JL; Porchet N
Eur J Endocrinol; 2009 Feb; 160(2):227-31. PubMed ID: 19029228
[TBL] [Abstract][Full Text] [Related]
2. Genetics of pheochromocytoma and paraganglioma in Spanish patients.
Cascón A; Pita G; Burnichon N; Landa I; López-Jiménez E; Montero-Conde C; Leskelä S; Leandro-García LJ; Letón R; Rodríguez-Antona C; Díaz JA; López-Vidriero E; González-Neira A; Velasco A; Matias-Guiu X; Gimenez-Roqueplo AP; Robledo M
J Clin Endocrinol Metab; 2009 May; 94(5):1701-5. PubMed ID: 19258401
[TBL] [Abstract][Full Text] [Related]
3. Rationalization of genetic testing in patients with apparently sporadic pheochromocytoma/paraganglioma.
Cascón A; López-Jiménez E; Landa I; Leskelä S; Leandro-García LJ; Maliszewska A; Letón R; de la Vega L; García-Barcina MJ; Sanabria C; Alvarez-Escolá C; Rodríguez-Antona C; Robledo M
Horm Metab Res; 2009 Sep; 41(9):672-5. PubMed ID: 19343621
[TBL] [Abstract][Full Text] [Related]
4. Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.
Erlic Z; Rybicki L; Peczkowska M; Golcher H; Kann PH; Brauckhoff M; Müssig K; Muresan M; Schäffler A; Reisch N; Schott M; Fassnacht M; Opocher G; Klose S; Fottner C; Forrer F; Plöckinger U; Petersenn S; Zabolotny D; Kollukch O; Yaremchuk S; Januszewicz A; Walz MK; Eng C; Neumann HP;
Clin Cancer Res; 2009 Oct; 15(20):6378-85. PubMed ID: 19825962
[TBL] [Abstract][Full Text] [Related]
5. Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Benn DE; Croxson MS; Tucker K; Bambach CP; Richardson AL; Delbridge L; Pullan PT; Hammond J; Marsh DJ; Robinson BG
Oncogene; 2003 Mar; 22(9):1358-64. PubMed ID: 12618761
[TBL] [Abstract][Full Text] [Related]
6. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas.
Mannelli M; Castellano M; Schiavi F; Filetti S; Giacchè M; Mori L; Pignataro V; Bernini G; Giachè V; Bacca A; Biondi B; Corona G; Di Trapani G; Grossrubatscher E; Reimondo G; Arnaldi G; Giacchetti G; Veglio F; Loli P; Colao A; Ambrosio MR; Terzolo M; Letizia C; Ercolino T; Opocher G;
J Clin Endocrinol Metab; 2009 May; 94(5):1541-7. PubMed ID: 19223516
[TBL] [Abstract][Full Text] [Related]
7. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Benn DE; Richardson AL; Marsh DJ; Robinson BG
Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077
[TBL] [Abstract][Full Text] [Related]
8. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
[TBL] [Abstract][Full Text] [Related]
9. Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.
Schiavi F; Boedeker CC; Bausch B; Peçzkowska M; Gomez CF; Strassburg T; Pawlu C; Buchta M; Salzmann M; Hoffmann MM; Berlis A; Brink I; Cybulla M; Muresan M; Walter MA; Forrer F; Välimäki M; Kawecki A; Szutkowski Z; Schipper J; Walz MK; Pigny P; Bauters C; Willet-Brozick JE; Baysal BE; Januszewicz A; Eng C; Opocher G; Neumann HP;
JAMA; 2005 Oct; 294(16):2057-63. PubMed ID: 16249420
[TBL] [Abstract][Full Text] [Related]
10. Testing new susceptibility genes in the cohort of apparently sporadic phaeochromocytoma/paraganglioma patients with clinical characteristics of hereditary syndromes.
Pęczkowska M; Kowalska A; Sygut J; Waligórski D; Malinoc A; Janaszek-Sitkowska H; Prejbisz A; Januszewicz A; Neumann HP
Clin Endocrinol (Oxf); 2013 Dec; 79(6):817-23. PubMed ID: 23551045
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
12. Somatic mutation analysis of the SDHB, SDHC, SDHD, and RET genes in the clinical assessment of sporadic and hereditary pheochromocytoma.
Weber A; Hoffmann MM; Neumann HP; Erlic Z
Horm Cancer; 2012 Aug; 3(4):187-92. PubMed ID: 22573489
[TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of pheochromocytoma patients with germline mutations in SDHD.
Dannenberg H; van Nederveen FH; Abbou M; Verhofstad AA; Komminoth P; de Krijger RR; Dinjens WN
J Clin Oncol; 2005 Mar; 23(9):1894-901. PubMed ID: 15774781
[TBL] [Abstract][Full Text] [Related]
15. A decade (2001-2010) of genetic testing for pheochromocytoma and paraganglioma.
Buffet A; Venisse A; Nau V; Roncellin I; Boccio V; Le Pottier N; Boussion M; Travers C; Simian C; Burnichon N; Abermil N; Favier J; Jeunemaitre X; Gimenez-Roqueplo AP
Horm Metab Res; 2012 May; 44(5):359-66. PubMed ID: 22517557
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of patients with pediatric pheochromocytoma.
Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes.
Gill AJ; Benn DE; Chou A; Clarkson A; Muljono A; Meyer-Rochow GY; Richardson AL; Sidhu SB; Robinson BG; Clifton-Bligh RJ
Hum Pathol; 2010 Jun; 41(6):805-14. PubMed ID: 20236688
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in pheochromocytoma: increasing importance for clinical decision making.
Bornstein SR; Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076
[TBL] [Abstract][Full Text] [Related]
19. Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation.
Toledo SP; Lourenço DM; Sekiya T; Lucon AM; Baena ME; Castro CC; Bortolotto LA; Zerbini MC; Siqueira SA; Toledo RA; Dahia PL
J Clin Endocrinol Metab; 2015 Feb; 100(2):E308-18. PubMed ID: 25389632
[TBL] [Abstract][Full Text] [Related]
20. Phaeochromocytoma, new genes and screening strategies.
Gimenez-Roqueplo AP; Lehnert H; Mannelli M; Neumann H; Opocher G; Maher ER; Plouin PF;
Clin Endocrinol (Oxf); 2006 Dec; 65(6):699-705. PubMed ID: 17121518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
